LA Times Columnist Targets CIRM; Structural Changes Needed

The California stem cell agency, which has “self-righteously” opposed better public oversight of its activities, should be altered to create a research program that “exemplifies not only good science, but good government,” a Pulitzer Prize-winning columnist said today in the Los Angeles Times.

While noting that the agency has funded “important work,” Mic…